The Appearance Anxiety Inventory: validation of a process measure in the treatment of body dysmorphic disorder
- PMID: 23823485
- DOI: 10.1017/S1352465813000556
The Appearance Anxiety Inventory: validation of a process measure in the treatment of body dysmorphic disorder
Abstract
Background: At present there are no measures to identify the cognitive processes and behaviours that might mediate the outcome of treatment in people with Body Dysmorphic Disorder (BDD).
Aims: To develop and validate a process measure that can be used to assess the progress of patients throughout therapy and in research for BDD.
Method: The psychometric properties of the Appearance Anxiety Inventory (AAI) were explored in a clinical group of participants diagnosed with BDD (Study 1) and in a non-clinical community group with high appearance concerns (Study 2). Item characteristics, reliability, and factor structure were analysed. Convergent validity with measures of related symptoms was assessed.
Results: The AAI was found to have good test-retest reliability and convergent validity in the measurement of appearance anxiety. It was also sensitive to change during treatment. The scale was found to have a two-factor structure in the clinical group, with one factor characterized by avoidance, and a second factor comprised of threat monitoring. However, in the community sample it appeared to have a one-factor structure.
Conclusion: The results suggest that the AAI has the psychometric properties to determine whether changes in cognitive processes and behaviours can mediate the outcome following treatment in patients with BDD. This supports its potential usefulness in clinical and research settings.
Similar articles
-
Cognitive behaviour therapy for adolescents with body dysmorphic disorder: a case series.Behav Cogn Psychother. 2012 Jul;40(4):452-61. doi: 10.1017/S1352465812000100. Epub 2012 Apr 12. Behav Cogn Psychother. 2012. PMID: 22494800
-
Psychometric evaluation of the appearance anxiety inventory in adolescents with body dysmorphic disorder.Cogn Behav Ther. 2024 May;53(3):254-266. doi: 10.1080/16506073.2023.2299837. Epub 2024 Jan 4. Cogn Behav Ther. 2024. PMID: 38174353
-
Efficacy of cognitive behaviour therapy versus anxiety management for body dysmorphic disorder: a randomised controlled trial.Psychother Psychosom. 2014;83(6):341-53. doi: 10.1159/000360740. Epub 2014 Oct 16. Psychother Psychosom. 2014. PMID: 25323062 Clinical Trial.
-
Screening tools for body dysmorphic disorder in a cosmetic surgery setting.Laryngoscope. 2011 Dec;121(12):2535-41. doi: 10.1002/lary.21728. Laryngoscope. 2011. PMID: 22109751 Review.
-
Body dysmorphic disorder in patients who seek appearance-enhancing medical treatments.Oral Maxillofac Surg Clin North Am. 2010 Nov;22(4):445-53. doi: 10.1016/j.coms.2010.07.002. Oral Maxillofac Surg Clin North Am. 2010. PMID: 20970710 Review.
Cited by
-
Therapist-guided, Internet-delivered cognitive behaviour therapy for adolescents with body dysmorphic disorder: A feasibility trial with long-term follow-up.Internet Interv. 2023 Nov 16;34:100688. doi: 10.1016/j.invent.2023.100688. eCollection 2023 Dec. Internet Interv. 2023. PMID: 38034863 Free PMC article.
-
Prosthodontic Rehabilitation's Role in Alleviating Anxiety and Depression in Mucormycosis-Induced Maxillectomy Patients Post-COVID-19.Med Sci Monit. 2023 Nov 24;29:e941488. doi: 10.12659/MSM.941488. Med Sci Monit. 2023. PMID: 37997301 Free PMC article.
-
Health Consequences of Familial Negative Weight Talk Across the Spectrum of Gender Diversity.Curr Nutr Rep. 2023 Dec;12(4):581-593. doi: 10.1007/s13668-023-00501-z. Epub 2023 Oct 14. Curr Nutr Rep. 2023. PMID: 37837600 Review.
-
Influence of Prosthodontic Rehabilitation Using Zygomatic Implants in Covid 19 Related Mucormycosis (Rhino-Orbital-Cerebral) Maxillectomy Patients Upon Post-Operative Stress, Anxiety and Functional Impairment: A Prospective Cohort Study.Clin Interv Aging. 2023 Aug 1;18:1201-1219. doi: 10.2147/CIA.S412625. eCollection 2023. Clin Interv Aging. 2023. PMID: 37547381 Free PMC article.
-
Effectiveness of Internet-based cognitive-behavioural therapy for obsessive-compulsive disorder (OCD-NET) and body dysmorphic disorder (BDD-NET) in the Swedish public health system using the RE-AIM implementation framework.Internet Interv. 2023 Feb 15;31:100608. doi: 10.1016/j.invent.2023.100608. eCollection 2023 Mar. Internet Interv. 2023. PMID: 36852382 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical